![](/img/cover-not-exists.png)
AT-11 * FINAL RESULTS FROM THE RANDOMIZED PHASE II TRIAL AVAREG (ML25739) WITH BEVACIZUMAB (BEV) OR FOTEMUSTINE (FTM) IN RECURRENT GBM
Brandes, A. A., Finocchiaro, G., Zagonel, V., Reni, M., Fabi, A., Caserta, C., Clavarezza, M., Maiello, E., Carteni, G., Rosti, G., Eoli, M., Lombardi, G., Monteforte, M., Agati, R., Eusebi, V., GalliVolume:
16
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/nou237.11
Date:
November, 2014
File:
PDF, 29 KB
english, 2014